Key result
TTVR abolishes torrential TR, enabling cessation of diuretic and antiviral therapies.
Why the study?
Severe tricuspid regurgitation causes systemic venous congestion, multiorgan dysfunction, and high mortality, yet isolated tricuspid surgery is rarely performed.
Does transcatheter tricuspid valve replacement (TTVR) improve cross-organ function and allow withdrawal of supportive therapies in a patient with severe tricuspid regurgitation and multiorgan dysfunction?
Case Report (n=1)
Does transcatheter tricuspid valve replacement (TTVR) improve cross-organ function and allow withdrawal of supportive therapies in a patient with severe tricuspid regurgitation and multiorgan dysfunction?
Answers are grounded in this paper and cite their sources.
TTVR can provide systemic benefits beyond cardiac function by reversing venous congestion-induced multiorgan dysfunction, potentially allowing withdrawal of supportive therapies like diuretics and antivirals.
BACKGROUND: Transcatheter tricuspid valve replacement (TTVR) is an emerging option for patients with severe tricuspid regurgitation (TR) at prohibitive surgical risk. Severe TR is associated with systemic venous congestion, multiorgan dysfunction, and high mortality, yet isolated tricuspid surgery is rarely performed. CASE SUMMARY: A 68-year-old woman with prior double mechanical valve replacement, chronic kidney disease, and hepatitis B, treated with entecavir, presented with dyspnea and edema. Imaging revealed torrential TR with a 43-mm annulus. Because of high surgical risk, she underwent successful TTVR. TR abolition allowed cessation of diuretics and antiviral therapy after normalization of hepatic tests and viral load. DISCUSSION: This case illustrates how TTVR-mediated venous decongestion can reverse renal and hepatic alterations and enable cessation of supportive therapies. TAKE-HOME MESSAGES: TTVR can abolish TR, improve right-heart hemodynamics, and provide systemic benefits beyond cardiac function. Venous decongestion may enable cross-organ recovery and allow withdrawal of diuretics and antiviral therapy.
No takes yet. Share an insight, caveat, or question.
Bardeesi et al. (2026) conducted a case report in Severe tricuspid regurgitation (n=1). Transcatheter tricuspid valve replacement (TTVR) was evaluated on TR abolition and cross-organ recovery. Transcatheter tricuspid valve replacement successfully abolished torrential tricuspid regurgitation in a 68-year-old woman, enabling the cessation of diuretic and antiviral therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: